Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon.

Abstract

Portal hypertension (PH) is responsible for the most severe complications of cirrhosis and leading cause of death and liver transplantation. The standard pharmacological treatment available for PH currently consists of the use of a non-selective beta-blocker. However, a significant proportion of patients do not respond to pharmacological treatment. This has… (More)
DOI: 10.1007/s12072-017-9806-1

Topics

3 Figures and Tables

Cite this paper

@article{Kang2017NoveltiesIT, title={Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon.}, author={Seong Hee Kang and Moon Young Kim and Soon Koo Baik}, journal={Hepatology international}, year={2017} }